BAVARIAN NORDIC

SL STRATEGIES, LLC representing BAVARIAN NORDIC · Q1 2026 · $40,000 · view on lda.senate.gov ↗

Issues lobbied

BUDBudget/Appropriations
Fiscal Year 2027 HHS Appropriations for Project BioShield Special Reserve Fund
HCRHealth Issues
Pandemic All Hazards Preparedness Act (PAHPA) reauthorization

Key facts

Filing UUID: eca4ab04-5501-4c45-bafc-cf6bb5bd92cc
Filing type: Q1
Filing period: first_quarter
Filing year: 2026
Posted: 2026-05-04T21:52:50-04:00
Registrant (lobbyist): SL STRATEGIES, LLC
Client: BAVARIAN NORDIC
Client location: DC / US
Client description: Pharmaceutical company
Income reported: $40,000
Expenses reported: —